Annual Drug Patent Expirations for VASCEPA
Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are sixty-nine patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for VASCEPA.
This drug has two hundred and ninety-five patent family members in forty-four countries.
The generic ingredient in VASCEPA is icosapent ethyl. Two suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
